Technology | October 19, 2008

AGA Medical Features AMPLATZER Muscular VSD Occluder for Ventricular Septal Defect Closure

At TCT 2008 AGA Medical Corp. highlighted its self-expanding AMPLATZER Muscular VSD Occluder for complex ventricular septal defect (VSD) repair in patients considered to be high-risk for standard transatrial or transarterial surgical repair.

AGA Medical designed the AMPLATZER Muscular VSD Occluder to allow closure of muscular ventricular defects using a minimally-invasive catheter procedure instead of surgery.

The Muscular VSD Occluder has two concentric discs and a long waist to accommodate the thicker portion of the ventricular septum. Polyester fabric inserts help close the hole and provide a foundation for growth of tissue over the occluder after placement. The physician deploys the occluder to expand each disc on either side of the defect, closing off the hole.

October 2008

Related Content

Gore Cardioform ASD Occluder Receives FDA Approval
Technology | Structural Heart Occluders | June 10, 2019
W. L. Gore & Associates (Gore) announced the U.S. Food and Drug Administration’s (FDA’s) premarket approval (PMA)...
Le Bonheur Children's Hospital Implants First Abbott Amplatzer Piccolo Occluder
News | Structural Heart Occluders | February 13, 2019
Le Bonheur Children's Hospital cardiologists in Memphis, Tenn., implanted the Amplatzer Piccolo Occluder, the world's...
FDA Approves Abbott's Amplatzer Piccolo Occluder
News | Structural Heart Occluders | January 16, 2019
Abbott announced the U.S. Food and Drug Administration (FDA) approved the Amplatzer Piccolo Occluder to treat patent...
FDA Approves Gore Cardioform Septal Occluder for PFO Closure Prevent Recurrent Ischemic Stroke
Technology | Structural Heart Occluders | April 03, 2018
April 3, 2018 — Following the unprecedented Gore REDUCE Clinical Study conclusion that closure of patent foramen oval
University of Alabama at Birmingham, Amplatzer PFO Occluder, first implementation
News | Structural Heart Occluders | February 15, 2017
Doctors at the University of Alabama at Birmingham have implemented the first U.S. Food and Drug Administration (FDA)-...
Amplatzer PFO Occluder, St. Jude Medical, Baylor Heart and Vascular Services, Fort Worth, Texas, first patients
News | Structural Heart Occluders | February 01, 2017
Baylor Heart and Vascular Services at Fort Worth in November became the first program in Texas to implant the Amplatzer...
Overlay Init